TSX open
Loading markets…

Advertisement

PARTNER SPOTLIGHT

CIBC Investor's Edge

Get 200 free trades when you open an eligible CIBC Investor's Edge account.

  • 200 free stock & ETF trades
  • Unlimited commission-free trades on 180+ select ETFs
  • Offer ends September 30, 2026
Stocks/NASDAQ/MEDS

DataMEDS AI, Inc. (MEDS : NASDAQ)

Common Stock

$6.07

USD

+4.45 (274.69%)

Last updated: 2026-09-16

Get MEDS alerts:

MEDS

DataMEDS AI, Inc.

Source:WealthAwesomeWealthAwesome
$3.27 (116.79%)
30 day period
$0.85$3.46$6.07Aug 5Aug 26Sep 16

Performance

1 Day

+274.69%

1 Week

+613.28%

1 Month

+307.38%

YTD

+64.05%

Key Statistics

Market Cap

$18.59M

52W High

$75.00

52W Low

$0.82

P/E Ratio

-

50 Day MA

$2.06

200 Day MA

$9.42

Beta

-

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
9/16/2026$4.04$12.31$4.00$6.07$6.07186,414,876
9/15/2026$0.89$3.85$0.86$1.62$1.6265,061,223
9/14/2026$0.88$0.90$0.86$0.87$0.8756,673
9/11/2026$0.91$0.94$0.86$0.90$0.9087,965
9/10/2026$0.88$0.90$0.85$0.89$0.8979,700
9/9/2026$0.87$0.95$0.85$0.85$0.85148,600
9/8/2026$0.92$0.92$0.85$0.87$0.87135,800
9/4/2026$0.97$1.04$0.92$0.92$0.92311,500
9/3/2026$1.02$1.03$0.95$0.96$0.9652,000
9/2/2026$0.97$1.05$0.93$1.03$1.03120,600

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MEDS's historical volatility

HistoricalForecast68%95%
US$0.03US$348.22US$696.41US$1044.60US$1392.78US$1740.97TodayJun 17Aug 3Sep 16Oct 29Dec 12Jan 24

30-Day Vol

456.0%

Annualized

90-Day Vol

327.1%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

US$7.26

Expected price

HorizonExpected68% Range (1σ)
30 trading daysUS$6.44US$1.34US$31.07
60 trading daysUS$6.84US$0.74US$63.29
90 trading daysUS$7.26US$0.48US$110.75

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About DataMEDS AI, Inc.

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services, . The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Financials

Revenue (TTM)
$8.02M
EBITDA
$-55.39M
Profit Margin
0.00%
ROE (TTM)
0.00%
EPS (Diluted)
-48.30
Book Value
-6.88

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About MEDS.US

Market movers

Recent NASDAQ movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
DLXYDelixy Holdings Limited Ordinary Shares$2.29+451.81%
SNYRSynergy CHC Corp. Common Stock$0.27+234.15%
QCLSQ/C Technologies, Inc.$0.96+118.45%
AEHLAntelope Enterprise Holdings Ltd$9.22+78.68%
ZTGZenta Group Company Limited$1.18+75.33%
PDSBPDS Biotechnology Corp$0.99+69.25%
TPSTTempest Therapeutics Inc$1.21+60.18%
AMPGZAmplitech Group, Inc. Series B Right$0.19+41.54%

Advertisement